General Statement of Disclosure:
CONSULTING FEES/HONORARIA: Astra Zeneca(MODEST) EQUITY INTERESTS/STOCK OPTIONS: Doximity(MODEST), Citrus Oncology(NONE) RESEARCH/RESEARCH GRANTS: Medtronic(NONE) SALARY: ProviderLoop(SIGNIFICANT)
The ACC will perform system updates on Oct. 15 from 8-11 p.m. ET. During this time, online purchases and payment processing will be unavailable. Thank you for your understanding.
CONSULTING FEES/HONORARIA: Astra Zeneca(MODEST) EQUITY INTERESTS/STOCK OPTIONS: Doximity(MODEST), Citrus Oncology(NONE) RESEARCH/RESEARCH GRANTS: Medtronic(NONE) SALARY: ProviderLoop(SIGNIFICANT)